America’s Pharmacist in Chief
NegativeU.S News

In a controversial move, the President has taken on the role of a drug marketer, promoting pharmaceutical products while Pfizer benefits from a tariff break. This situation raises concerns about the intersection of politics and healthcare, as it blurs the lines between public service and corporate interests. The implications of such actions could undermine trust in government and lead to increased scrutiny of pharmaceutical practices.
— Curated by the World Pulse Now AI Editorial System